Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodies

Journal of the European Academy of Dermatology and Venereology

Volumn 10, Issue 1, 1998, Pages 28-35

  Bhol, Kailash ^b   Tyagi, Shivraj ^b   Natarajan, K ^b   Nagarwalla, Neville ^b   Ahmed, A Razzaque ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Enzyme linked immunosorbent assay; Pemphigus vulgaris; Recombinant antigen

Indexed keywords

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOBLOTTING; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; PEMPHIGOID, BULLOUS; RABBITS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0031930872     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00139-6     Document Type: Article

References (22)

1. Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific autoantibody mediated disease. J Clin Invest 1989;83:1443-1448.
2. Amagai M, Klaus Kovtum V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris: a disease of cell adhesion. Cell 1991;67:869-877.
3. Amagai M, Karpati S, Prussick R, Klaus Kovtum V, Stanley JR. Autoantibodies against the amino terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992;90:919-926.
4. Stanley JR, Yaar M, Hawley-Nelson P, Katz S. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982;70:281-285.
5. Bhol K, Natarajan K, Nagarwalla N, et al. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 1995;92:5239-5243.
6. Ahmed AR, Mohimen A, Yunis EJ, et al. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med 1993;177:419-424.
7. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceous antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990;94:327-331.
8. Sabolinski ML, Beutner EH, Karasny S. Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceous sera in immunofluorescence tests on monkey and guinea pig esophagus. J Invest Dermatol 1982;88:545-547.
9. Smith DB, Johnson KS. Single step purification of polypeptide expressed in E. coli as fusions with glutathione S. transferase. Gene 1988;67:31-40.
10. Mohimen A, Ahmed AR. Comparison of an indirect immunofluorescence assay and a modified sensitive immunoblot assay for the study of the autoantibody in pemphigus vulgaris. Arch Dermatol Res 1995;287:202-208.
11. Guidice GJ, Wilske KC, Anhalt GJ, et al. Development of an ELISA to detect anti BP-180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 1994;102:878-881.
12. Emery DJ, Diaz LA, Fairley JA, et al. Pemphigus foliaceous and pemphigus vulgaris autoantibodies react with the extra-cellular domain of desmoglein-1. J Invest Dermatol 1995;104:323-328.
13. Larsen RJ, Marx LM. An Introduction to Mathematical Statistics and its Application. New Jersey: Prentice Hall, 1986;545 pp.
14. Scheffe H. The Analysis of Variance. New York: Wiley, 1959;73-75.
15. Ioannides D, Hytinoglou P, Phelps RG, Bystryn JC. Regional variation in the expression of pemphigus foliaceous, pemphigus erythematosus, and pemphigus vulgaris antigen in human skin. J Invest Dermatol 1991;96:159-161.
16. Sison-Fonacier L, Bystryn J-C. Heterogeneity of pemphigus vulgaris antigens. Arch Dermatol 1987;123:1507-1510.
17. Cozzani E, Kanitakis J, Nicolas JF, Thivolet T. Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res 1994;286:295-299.
18. Amagai M, Hashimoto T, Shimizuz N, Nishikama T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994;94:59-67.
19. Guidice GJ, Emery DJ, Zelickson BD, et al. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP-180 ectodomain. J Immunol 1993;151:5742-5750.
20. Mohimen A, Narula M, Ruocco V, Pisani M, Ahmed AR. Presence of the autoantibodies in healthy relatives of Italian patients with pemphigus vulgaris. Arch Dermatol Res 1993;285:176-177.
21. Firoz A, Mobini N, Bahar K, Shams S, Ahmed AR, Dowlatt Y. Presence of anti-desmoglein 3 autoantibodies in healthy relatives of Iranian patients with pemphigus vulgaris. Gulf J Dermatol Venerol 1996;3:18-20.
22. Brandsen R, Frusic-Zlotkin M, Lyubimov H, et al. Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting. J Am Acad Dermatol 1997;36:44-52.